{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:48Z","timestamp":1772165688185,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02126-w","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:15:00Z","timestamp":1766142900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differentiating tumor recurrence and pseudoprogression in postoperative gliomas using pseudo-continuous arterial spin labeling (pCASL) technique"],"prefix":"10.1186","volume":"26","author":[{"given":"Peiquan","family":"Liu","sequence":"first","affiliation":[]},{"given":"Yujie","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Xudong","family":"Ai","sequence":"additional","affiliation":[]},{"given":"Weiyin","family":"Vivian Liu","sequence":"additional","affiliation":[]},{"given":"Hongquan","family":"Zhu","sequence":"additional","affiliation":[]},{"given":"Yujie","family":"Ding","sequence":"additional","affiliation":[]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Tengfei","family":"Chao","sequence":"additional","affiliation":[]},{"given":"Jiaxuan","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Wenzhen","family":"Zhu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2126_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/neuonc\/nov022","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, et al. Response to \u201cThe epidemiology of glioma in adults: a \u2018state of the science\u2019 review\u201d. Neuro-Oncology. 2015;17:624\u201326. https:\/\/doi.org\/10.1093\/neuonc\/nov022.","journal-title":"Neuro-Oncology"},{"key":"2126_CR2","doi-asserted-by":"publisher","unstructured":"Ostrom QT, et al. CBTRUS Statistical report: primary brain and other central nervous System tumors diagnosed in the United States in 2015-2019. Neuro Oncol. 2022;24(v1\u2013v95). https:\/\/doi.org\/10.1093\/neuonc\/noac202.","DOI":"10.1093\/neuonc\/noac202"},{"key":"2126_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","volume":"18","author":"TS van Solinge","year":"2022","unstructured":"van Solinge TS, Nieland L, Chiocca EA, Broekman MLD. Advances in local therapy for glioblastoma - taking the fight to the tumour. Nat Rev Neurol. 2022;18:221\u201336. https:\/\/doi.org\/10.1038\/s41582-022-00621-0.","journal-title":"Nat Rev Neurol"},{"key":"2126_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2020.02.025","volume":"477","author":"LS Hu","year":"2020","unstructured":"Hu LS, Hawkins-Daarud A, Wang L, Li J, Swanson KR. Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett. 2020;477:97\u2013106. https:\/\/doi.org\/10.1016\/j.canlet.2020.02.025.","journal-title":"Cancer Lett"},{"key":"2126_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ijrobp.2021.12.007","volume":"112","author":"A Stock","year":"2022","unstructured":"Stock A, et al. Pseudoprogression is frequent after front-line radiation therapy in pediatric low-grade glioma: results from the German low-grade glioma cohort. Int J Radiat Oncol. 2022;112:1190\u2013202. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.12.007.","journal-title":"Int J Radiat Oncol"},{"key":"2126_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jmri.26171","volume":"48","author":"SC Thust","year":"2018","unstructured":"Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imag. 2018;48:571\u201389. https:\/\/doi.org\/10.1002\/jmri.26171.","journal-title":"J Magn Reson Imag"},{"key":"2126_CR7","doi-asserted-by":"publisher","first-page":"e4719","DOI":"10.1002\/nbm.4719","volume":"35","author":"S Chawla","year":"2022","unstructured":"Chawla S, et al. Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma. NMR Biomed. 2022;35:e4719. https:\/\/doi.org\/10.1002\/nbm.4719.","journal-title":"NMR Biomed"},{"key":"2126_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-021-03363-z","volume":"592","author":"M Platten","year":"2021","unstructured":"Platten M, et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature. 2021;592:463\u201368. https:\/\/doi.org\/10.1038\/s41586-021-03363-z.","journal-title":"Nature"},{"key":"2126_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11060-018-03076-w","volume":"142","author":"M Voss","year":"2019","unstructured":"Voss M, et al. Contrast enhancing spots as a new pattern of late onset pseudoprogression in glioma patients. J Neuro-Oncol. 2019;142:161\u201369. https:\/\/doi.org\/10.1007\/s11060-018-03076-w.","journal-title":"J Neuro-Oncol"},{"key":"2126_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.diii.2013.06.010","volume":"94","author":"JC Ferre","year":"2013","unstructured":"Ferre JC, et al. Arterial spin labeling (ASL) perfusion: techniques and clinical use. Diagn Interv Imag. 2013;94:1211\u201323. https:\/\/doi.org\/10.1016\/j.diii.2013.06.010.","journal-title":"Diagn Interv Imag"},{"key":"2126_CR11","doi-asserted-by":"publisher","unstructured":"Tanaka F, et al. Pseudocontinuous arterial spin labeling: clinical applications and usefulness in head and neck entities. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14163872.","DOI":"10.3390\/cancers14163872"},{"key":"2126_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3174\/ajnr.A6384","volume":"41","author":"H Maral","year":"2020","unstructured":"Maral H, Ertekin E, Tuncyurek O, Ozsunar Y. Effects of susceptibility artifacts on perfusion MRI in patients with primary brain tumor: a comparison of arterial spin-labeling versus DSC. AJNR Am J Neuroradiol. 2020;41:255\u201361. https:\/\/doi.org\/10.3174\/ajnr.A6384.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2126_CR13","first-page":"2790","volume":"7","author":"J Jiang","year":"2014","unstructured":"Jiang J, et al. Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors. Int J Clin Exp Pathol. 2014;7:2790\u201399.","journal-title":"Int J Clin Exp Pathol"},{"key":"2126_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/neuonc\/nox227","volume":"20","author":"R Calmon","year":"2018","unstructured":"Calmon R, et al. Cerebral blood flow changes after radiation therapy identifies pseudoprogression in diffuse intrinsic pontine gliomas. Neuro Oncol. 2018;20:994\u20131002. https:\/\/doi.org\/10.1093\/neuonc\/nox227.","journal-title":"Neuro Oncol"},{"key":"2126_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12880-017-0183-y","volume":"17","author":"ZC Liu","year":"2017","unstructured":"Liu ZC, et al. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial. BMC Med Imag. 2017;17:10. https:\/\/doi.org\/10.1186\/s12880-017-0183-y.","journal-title":"BMC Med Imag"},{"key":"2126_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11060-020-03475-y","volume":"147","author":"P Manning","year":"2020","unstructured":"Manning P, et al. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol. 2020;147:681\u201390. https:\/\/doi.org\/10.1007\/s11060-020-03475-y.","journal-title":"J Neurooncol"},{"key":"2126_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441\u201346. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.036.","journal-title":"Eur J Cancer"},{"key":"2126_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.mri.2012.06.010","volume":"30","author":"V Kumar","year":"2012","unstructured":"Kumar V, et al. Radiomics: the process and the challenges. Magn Reson Imag. 2012;30:1234\u201348. https:\/\/doi.org\/10.1016\/j.mri.2012.06.010.","journal-title":"Magn Reson Imag"},{"key":"2126_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.09.007","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, et al. Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer. EBioMedicine. 2018;36:171\u201382. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.007.","journal-title":"EBioMedicine"},{"key":"2126_CR20","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1038\/s41467-020-18162-9","volume":"11","author":"Z Liu","year":"2020","unstructured":"Liu Z, et al. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11:4308. https:\/\/doi.org\/10.1038\/s41467-020-18162-9.","journal-title":"Nat Commun"},{"key":"2126_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fonc.2015.00272","volume":"5","author":"C Parmar","year":"2015","unstructured":"Parmar C, et al. Radiomic machine-learning classifiers for prognostic biomarkers of head and Neck cancer. Front Oncol. 2015;5:272. https:\/\/doi.org\/10.3389\/fonc.2015.00272.","journal-title":"Front Oncol"},{"key":"2126_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.radonc.2018.01.009","volume":"129","author":"YL Wang","year":"2018","unstructured":"Wang YL, et al. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging. Radiother Oncol. 2018;129:68\u201374. https:\/\/doi.org\/10.1016\/j.radonc.2018.01.009.","journal-title":"Radiother Oncol"},{"key":"2126_CR23","doi-asserted-by":"publisher","first-page":"e9332","DOI":"10.1097\/MD.0000000000009332","volume":"96","author":"Q Xu","year":"2017","unstructured":"Xu Q, et al. Tumor recurrence versus treatment effects in glioma: a comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Med (baltim). 2017;96:e9332. https:\/\/doi.org\/10.1097\/MD.0000000000009332.","journal-title":"Med (baltim)"},{"key":"2126_CR24","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3892\/etm.2016.3225","volume":"11","author":"J Ye","year":"2016","unstructured":"Ye J, et al. Differentiation between recurrent gliomas and radiation necrosis using arterial spin labeling perfusion imaging. Exp Ther Med. 2016;11:2432\u201336. https:\/\/doi.org\/10.3892\/etm.2016.3225.","journal-title":"Exp Ther Med"},{"key":"2126_CR25","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/neuonc\/noy133","volume":"21","author":"JY Kim","year":"2019","unstructured":"Kim JY, et al. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients. Neuro Oncol. 2019;21:404\u201314. https:\/\/doi.org\/10.1093\/neuonc\/noy133.","journal-title":"Neuro Oncol"},{"key":"2126_CR26","first-page":"1061","volume":"22","author":"M Jovanovic","year":"2017","unstructured":"Jovanovic M, et al. Differentiation between progression and pseudoprogresion by arterial spin labeling MRI in patients with glioblastoma multiforme. J Buon. 2017;22:1061\u201367.","journal-title":"J Buon"},{"key":"2126_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00234-017-1955-3","volume":"60","author":"A Razek","year":"2018","unstructured":"Razek A, El-Serougy L, Abdelsalam M, Gaballa G, Talaat M. Differentiation of residual\/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics. Neuroradiology. 2018;60:169\u201377. https:\/\/doi.org\/10.1007\/s00234-017-1955-3.","journal-title":"Neuroradiology"},{"key":"2126_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.acra.2009.10.024","volume":"17","author":"Y Ozsunar","year":"2010","unstructured":"Ozsunar Y, et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol. 2010;17:282\u201390. https:\/\/doi.org\/10.1016\/j.acra.2009.10.024.","journal-title":"Acad Radiol"},{"key":"2126_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11060-017-2375-2","volume":"134","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017;134:495\u2013504. https:\/\/doi.org\/10.1007\/s11060-017-2375-2.","journal-title":"J Neurooncol"},{"key":"2126_CR30","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1200\/JCO.23.01059","volume":"41","author":"PY Wen","year":"2023","unstructured":"Wen PY, et al. RANO 2.0: update to the response assessment in Neuro-Oncology criteria for high- and low-grade gliomas in adults. J Clin Oncol. 2023;41:5187\u201399. https:\/\/doi.org\/10.1200\/JCO.23.01059.","journal-title":"J Clin Oncol"},{"key":"2126_CR31","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.patter.2022.100452","volume":"3","author":"Y Ning","year":"2022","unstructured":"Ning Y, et al. Shapley variable importance cloud for interpretable machine learning. Patterns (N Y). 2022;3:100452. https:\/\/doi.org\/10.1016\/j.patter.2022.100452.","journal-title":"Patterns (N Y)"},{"key":"2126_CR32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison NJ, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imag. 2010;29:1310\u201320. https:\/\/doi.org\/10.1109\/TMI.2010.2046908.","journal-title":"IEEE Trans Med Imag"},{"key":"2126_CR33","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1007\/s00330-022-09365-3","volume":"33","author":"J Zhang","year":"2023","unstructured":"Zhang J, et al. Diffusion-weighted imaging and arterial spin labeling radiomics features may improve differentiation between radiation-induced brain injury and glioma recurrence. Eur Radiol. 2023;33:3332\u201342. https:\/\/doi.org\/10.1007\/s00330-022-09365-3.","journal-title":"Eur Radiol"},{"key":"2126_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3414\/ME16-01-0033","volume":"55","author":"T Hepp","year":"2016","unstructured":"Hepp T, Schmid M, Gefeller O, Waldmann E, Mayr A. Approaches to regularized regression - a Comparison between gradient boosting and the Lasso. Methods Inf Med. 2016;55:422\u201330. https:\/\/doi.org\/10.3414\/ME16-01-0033.","journal-title":"Methods Inf Med"},{"key":"2126_CR35","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/0284185114550193","volume":"56","author":"SH Cho","year":"2015","unstructured":"Cho SH, et al. Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response. Acta Radiol. 2015;56:1042\u201350. https:\/\/doi.org\/10.1177\/0284185114550193.","journal-title":"Acta Radiol"},{"key":"2126_CR36","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s00330-016-4440-1","volume":"27","author":"N Fujima","year":"2017","unstructured":"Fujima N, et al. Prediction of the treatment outcome using intravoxel incoherent motion and diffusional kurtosis imaging in nasal or sinonasal squamous cell carcinoma patients. Eur Radiol. 2017;27:956\u201365. https:\/\/doi.org\/10.1007\/s00330-016-4440-1.","journal-title":"Eur Radiol"},{"key":"2126_CR37","doi-asserted-by":"publisher","unstructured":"Gutsche R, et al. Evaluation of fet pet radiomics feature repeatability in glioma patients. Cancers (Basel). 2021;13. https:\/\/doi.org\/10.3390\/cancers13040647.","DOI":"10.3390\/cancers13040647"},{"key":"2126_CR38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3174\/ajnr.A5112","volume":"38","author":"PD Chang","year":"2017","unstructured":"Chang PD, et al. A multiparametric model for mapping cellularity in glioblastoma using radiographically localized biopsies. AJNR Am J Neuroradiol. 2017;38:890\u201398. https:\/\/doi.org\/10.3174\/ajnr.A5112.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2126_CR39","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jmri.26556","volume":"49","author":"RD Chitalia","year":"2019","unstructured":"Chitalia RD, Kontos D. Role of texture analysis in breast MRI as a cancer biomarker: a review. J Magn Reson Imag. 2019;49:927\u201338. https:\/\/doi.org\/10.1002\/jmri.26556.","journal-title":"J Magn Reson Imag"},{"key":"2126_CR40","doi-asserted-by":"publisher","first-page":"E256","DOI":"10.1148\/radiol.2021219005","volume":"299","author":"MR Tomaszewski","year":"2021","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;299:E256. https:\/\/doi.org\/10.1148\/radiol.2021219005.","journal-title":"Radiology"},{"key":"2126_CR41","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s00330-018-5704-8","volume":"29","author":"C Su","year":"2019","unstructured":"Su C, et al. Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour. Eur Radiol. 2019;29:1986\u201396. https:\/\/doi.org\/10.1007\/s00330-018-5704-8.","journal-title":"Eur Radiol"},{"key":"2126_CR42","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.21037\/qims-22-32","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression. Quant Imag Med Surg. 2022;12:4805\u201322. https:\/\/doi.org\/10.21037\/qims-22-32.","journal-title":"Quant Imag Med Surg"},{"key":"2126_CR43","doi-asserted-by":"publisher","unstructured":"Quan G, et al. Role of dynamic susceptibility contrast perfusion MRI in glioma progression evaluation. J Oncol. 2021 (2021;1696387. https:\/\/doi.org\/10.1155\/2021\/1696387.","DOI":"10.1155\/2021\/1696387"},{"key":"2126_CR44","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00234-015-1571-z","volume":"57","author":"M Grade","year":"2015","unstructured":"Grade M, et al. A neuroradiologist\u2019s guide to arterial spin labeling MRI in clinical practice. Neuroradiology. 2015;57:1181\u2013202. https:\/\/doi.org\/10.1007\/s00234-015-1571-z.","journal-title":"Neuroradiology"},{"key":"2126_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1258\/ar.2011.110242","volume":"53","author":"H Thomsen","year":"2012","unstructured":"Thomsen H, Steffensen E, Larsson EM. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Acta Radiol. 2012;53:95\u2013101. https:\/\/doi.org\/10.1258\/ar.2011.110242.","journal-title":"Acta Radiol"},{"key":"2126_CR46","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1038\/s41598-020-62658-9","volume":"10","author":"T Hashido","year":"2020","unstructured":"Hashido T, Saito S, Ishida T. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas. Sci Rep. 2020;10:6121. https:\/\/doi.org\/10.1038\/s41598-020-62658-9.","journal-title":"Sci Rep"},{"key":"2126_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4103\/0973-1482.155978","volume":"12","author":"YF Wang","year":"2016","unstructured":"Wang YF, et al. Diagnostic significance of arterial spin labeling in the assessment of tumor grade in brain. J Cancer Res Ther. 2016;12:259\u201366. https:\/\/doi.org\/10.4103\/0973-1482.155978.","journal-title":"J Cancer Res Ther"},{"key":"2126_CR48","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/0284185112474916","volume":"54","author":"YJ Choi","year":"2013","unstructured":"Choi YJ, Kim HS, Jahng GH, Kim SJ, Suh DC. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging. Acta Radiol. 2013;54:448\u201354. https:\/\/doi.org\/10.1177\/0284185112474916.","journal-title":"Acta Radiol"},{"key":"2126_CR49","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3174\/ajnr.A4218","volume":"36","author":"AJ Prager","year":"2015","unstructured":"Prager AJ, et al. Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol. 2015;36:877\u201385. https:\/\/doi.org\/10.3174\/ajnr.A4218.","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02126-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:37:21Z","timestamp":1769171841000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-02126-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02126-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7561157\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Huazhong University of Science and Technology Tongji Medical College Affiliated Tongji Hospital, and the requirement for written informed consent was waived, in accordance with the basic principles of the Declaration of Helsinki (approval date: July 29, 2024, approval number: TJ-IRB202407107).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"In accordance with the ethical standards of our institution, we confirm that no identifying images or personal\/clinical details of participants are presented in this manuscript. All participant data used in the study were anonymized to ensure confidentiality and to prevent any compromise of anonymity.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}